Edition:
United States

Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

179.05USD
27 Oct 2016
Change (% chg)

-- (--)
Prev Close
$179.05
Open
--
Day's High
--
Day's Low
--
Volume
27
Avg. Vol
165
52-wk High
$195.20
52-wk Low
$147.84

Select another date:

Thu, Oct 27 2016

BRIEF-Lonza Group expects to reach 2018 guidance year early

* Says strong momentum in q3 gives us confidence to specify that core ebit is on track to cross 15% growth line for full-year 2016

BRIEF-Clovis oncology says entered into a manufacturing services agreement - sec filing

* Says Clovis Oncology and Lonza Ltd entered into a manufacturing services agreement - SEC filing

Lonza buys InterHealth in health push

ZURICH Swiss specialty chemicals and pharmaceutical ingredients company Lonza has announced a deal worth up to $300 million to buy InterHealth Nutraceuticals, a developer and manufacturer of nutritional ingredients used in dietary supplements.

Lonza buys InterHealth in health push

* Lonza to spend up to $300 million on health-supplements target

European shares rise on strong results from SAP and Lonza

LONDON, July 20 European shares edged up in early trade on Wednesday, with Swiss speciality chemicals and life sciences group Lonza and software firm SAP leading the market higher after reporting solid results.

Lonza raises outlook after double-digit core earnings rise in H1

ZURICH, July 20 Swiss speciality chemicals and life sciences group Lonza raised its guidance for 2016 after reporting the strongest earnings growth in its history during the first six month.

BRIEF-Lonza raises guidance for core EBIT growth in 2016

* Raising its guidance for core ebit growth and now expects a double-digit improvement in core ebit for full year of 2016

Select another date: